期刊文献+

脐血CD133^+细胞体外扩增巨核系祖细胞的研究

Ex Vivo Expansion of Megakaryocyte Progenitor Cells for CD133^+ Cells Derived from Human Umbilical Cord Blood
下载PDF
导出
摘要 本研究探讨脐血CD133+(UCB-CD133+)细胞体外扩增巨核系祖细胞的能力和最佳收获时间。采用免疫磁珠激活细胞分选系统(MACS)分选UCB-CD133+细胞,将纯化的UCB-CD133+细胞接种于含TPO、IL-3和SCF的无血清液体培养体系中体外扩增巨核系祖细胞,在培养第7、10和14天进行细胞计数,流式细胞仪检测扩增过程中CD133、CD34、CD41抗原表达的动态变化,并采用半固体法对不同扩增阶段的细胞进行巨核祖细胞集落形成单位(CFU-MK)培养。结果表明:培养至第7天时,UCB-CD133+细胞扩增效果最佳,扩增了8.2±2.2倍;培养至第14天,细胞总数扩增了116倍;培养至10天时,平均1个CD133+细胞所产生的CD133+CD41+和CD34+CD41+细胞数最多,分别为2.5±0.9和2.6±0.5个,所产生的CD41+细胞为20.3±5.9个;扩增前后的UCB-CD133+细胞均能形成CFU-MK,扩增第10天的UCB-CD133+细胞所形成的CFU-MK总数最多,CFU-MK扩增倍数为59.5±11.8倍。巨核细胞免疫组织化学染色显示,扩增后的巨核系细胞多呈幼稚状态,未见血小板形成。结论:UCB-CD133+细胞具有较强的体外扩增巨核系祖细胞的能力,培养第10天扩增效能最佳。 To study the expansion potentiality of megakaryocyte progenitor cells (MPCs) derived from human umbilical cord blood CD133^+ ( UCB-CD133^+ ) cells and determine the optimal harvest time. UCB-CD133^+ cells were purified from mononuclear cells (MNCs) by magnetic activated cell sorting (MACS) and seeded in serum-free liquid culture medium supplemented with thrombopoietin ( TPO), interleukin-3 ( IL-3 ) , and stem cell factor (SCF) to expand MPCs. At day 0, 6, 10 and 14 of culture , the total cell number was counted and the dynamic changes of CD133, CD34, and CD41 antigen expression during ex vivo expansion were analyzed by flow cytometry (FCM). At different expansion times, the CD133^+ cells were collected and cultured in collagen semisolid medium to carry out CFU-MK colony culture. The incidence of CFU-MK was calculated and the morphology of MPCs and CFU-MK were detected by immunohistochemisa-y and Wright-Giemsa staining. The results showed that UCB-CD133^+ cells optimally expanded at day 7 with expansion multiple of 8.2 ± 2.2 in serum-free liquid culture systems and the total cell number was expanded by 116-fold at day 14. At 10 days, each UCB-CD133 ^+ cell can form 2.5 ± 1.0, 2.6 ± 0.5 and 20.3 ± 5.9 cells of CD133 ^+CD41 ^+ ,CD34 ^+ CD41 ^+ and CD41 ^+ repectively, from which the number of CD133^+ CD41 ^+ and CD34 ^+ CD41 ^+ cells reach the highest. UCB-CD133 ^+ cells both before and after expansion could form CFU-MK, the total number of CFU-MK reached the peak from cells of 10 days expansion of UCB-CD133 ^+cells and the expansion multiple of CFU- MK was 59.5^+11.8. Immunohistochemical results indicated that the expanded megakaryocytic cells were immature and no sign of platelet formation. It is concluded that the human UCB-CD133^+ cells have a high abilitity of MPC expansion, 10 days of culture can be result in optimal expansion effect.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第3期645-649,共5页 Journal of Experimental Hematology
基金 贵州省科技计划发展项目,编号2051 2003JGY005
关键词 CD133^+细胞 造血干/祖细胞 巨核系祖细胞 体外扩增 脐血 CD133^+ cell hematopoietic stem/progenitor cell megakaryocyte progenitor cell ex vivo expansion umbilical cord blood
  • 相关文献

参考文献12

  • 1Kanamaru S, Kawano Y, Watanabe T, et al. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant. Stem Cells, 2000;18:190 - 195.
  • 2Du T, Iancu-Rubin C, Atweh GF, et al. Delayed platelet recovery following cord blood transplantation : insights from a mouse model. Blood ( ASH Annual Meeting Abstracts), 2005 ; 106 : 1727.
  • 3Bruno S, Gunetti M, Gammaitoni L, et al. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34^+ cells. Stem Cells, 2004 ;22 : 135 - 143.
  • 4Drayer AL, Smit Sibinga CT, Esselink MT, et al. In vitro megakaryocyte expansion in patients with delayed platelet engraftment ,after autologous stem cell transplantation. Ann Hematol, 2002;81:192 - 197.
  • 5Yao CL, Feng YH, Lin XZ, et al. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133 ( + ) cells. Stem Cells Dev, 2006; 15 : 70 - 78.
  • 6De-Wynter EA, Buck D, Hart C, et al. CD34^+ AC133^+ cells isolated from cord blood are highly enriched in long-term cultureinitiating cells, NOD/SCID-repopulating cells and dentritic cell progenitors. Stem Cells, 1998 ; 16:387 - 396.
  • 7马艳萍,邹萍,肖娟,黄士昂.脐血造血细胞中AC_(133)抗原表达及其功能特征研究[J].中华内科杂志,2002,41(12):798-800. 被引量:1
  • 8郝思国,孙关林,邬维礼,吴英理.人脐血CD133^+细胞体外短期培养中生物学特性的变化[J].中国实验血液学杂志,2003,11(6):569-575. 被引量:9
  • 9De Bruyn C, Delforge A, Martiat P, et al. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev, 2005 ; 14:415 -424.
  • 10Charrier S, Boiret N, Fouassier M, et al. Normal human bone marrow CD34( + ) CD133( + ) cells contain primitive cells able to produce different categories of colonyforming unit megakaryocytes in vitro. Exp Hematol, 2002; 30:1051 - 1060.

二级参考文献23

  • 1Tao H, Gaudry L, Rice A, et al. Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol,1999;27:293-301
  • 2Schatmer M, Lefebvre P, Mingolelli SS, et al. Thrombopoietinstimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells,1996;14:207-214
  • 3van den Oudenrijn S, von dcm Borne AE, de Haas M. Influence of medium components on ex vivo megakaryocyte expansion. J Hematother Stem Cell Res,2001;10:193-200
  • 4Lefebvre P, Winter JN, Kahn LE, et al. Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium. J Hematother,1999;8:199-208
  • 5Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood,2002;
  • 6Watts MJ, Somervaille TC, Ings SJ, et al. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. BrJ Haematol,2002;118:117-123
  • 7Lazzari L, Henschler R, Leechi L, et al. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+megakaryocytic cells. Haematologica,2000;85:25-30
  • 8van den Oudenrijn S, von dem Bome AE, de Haas M. Differences in megakaryocyte expansion potential between CD34 + stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol,2000;28:1054-1061
  • 9Mwarmtemi HH, Higuchi T, Sawai N, et al. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow. Transplantation,2000;69:1645-1654
  • 10Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.Haematologica,2003;88:379-387

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部